Payment overview · 2025
General Payments
$25.01
1 reported records · 1 companies
Healthcare provider profile · identity verified
Maria-Ann E Holubowicz, NP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · COLORADO SPRINGS, CO · NPI 1881293447
Verified facts
What the public records show
CMS Open Payments records show Maria-Ann E Holubowicz, NP received $25.01 in general payments during 2025 across 1 reported records.
Boston Scientific Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $25.01 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $25.01 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| General - Pain Management Normalized: general pain management |
Device | Boston Scientific Corporation | $25.01 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 245 | 38 |
| Atorvastatin Calcium | Atorvastatin Calcium | 224 | 37 |
| Levothyroxine Sodium | Levothyroxine Sodium | 220 | 36 |
| Lisinopril | Lisinopril | 191 | 30 |
| Pantoprazole Sodium | Pantoprazole Sodium | 185 | 29 |
| Amlodipine Besylate | Amlodipine Besylate | 175 | 28 |
| Trazodone Hcl | Trazodone Hcl | 172 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 137 | 30 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 137 | 23 |
| Furosemide | Furosemide | 119 | 21 |
| Sertraline Hcl | Sertraline Hcl | 118 | 16 |
| Metoprolol Tartrate | Metoprolol Tartrate | 109 | 18 |
| Eliquis | Apixaban | 100 | 14 |
| Famotidine | Famotidine | 94 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 92 | 13 |
| Losartan Potassium | Losartan Potassium | 91 | 17 |
| Potassium Chloride | Potassium Chloride | 91 | 16 |
| Metoprolol Succinate | Metoprolol Succinate | 90 | 17 |
| Omeprazole | Omeprazole | 80 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 78 | 14 |
| Gemtesa | Vibegron | 76 | 11 |
| Hydrochlorothiazide | Hydrochlorothiazide | 70 | 11 |
| Tamsulosin Hcl | Tamsulosin Hcl | 70 | 12 |
| Carvedilol | Carvedilol | 63 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 62 | suppressed |
| Pregabalin | Pregabalin | 62 | suppressed |
| Clonazepam | Clonazepam | 61 | suppressed |
| Jardiance | Empagliflozin | 59 | suppressed |
| Metformin Hcl | Metformin Hcl | 57 | 13 |
| Celecoxib | Celecoxib | 54 | suppressed |
| Memantine Hcl | Memantine Hcl | 54 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 53 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 51 | suppressed |
| Mirtazapine | Mirtazapine | 49 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 47 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | suppressed |
| Lamotrigine | Lamotrigine | 46 | suppressed |
| Xarelto | Rivaroxaban | 46 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 45 | 41 |
| Montelukast Sodium | Montelukast Sodium | 44 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 43 | 23 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 43 | suppressed |
| Ozempic | Semaglutide | 43 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 43 | 16 |
| Buspirone Hcl | Buspirone Hcl | 40 | 12 |
| Topiramate | Topiramate | 39 | suppressed |
| Zonisamide | Zonisamide | 38 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 36 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 36 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 35 | 14 |
| Latanoprost | Latanoprost | 35 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 34 | suppressed |
| Ibuprofen | Ibuprofen | 34 | 19 |
| Mounjaro | Tirzepatide | 34 | suppressed |
| Bupropion Xl | Bupropion Hcl | 32 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 32 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 31 | 30 |
| Meloxicam | Meloxicam | 31 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 31 | 19 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 31 | 29 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | suppressed |
| Olanzapine | Olanzapine | 30 | suppressed |
| Wegovy | Semaglutide | 30 | suppressed |
| Prednisone | Prednisone | 28 | 13 |
| Ramipril | Ramipril | 28 | suppressed |
| Finasteride | Finasteride | 27 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 26 | suppressed |
| Ezetimibe | Ezetimibe | 26 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 26 | suppressed |
| Jantoven | Warfarin Sodium | 26 | suppressed |
| Spironolactone | Spironolactone | 26 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 26 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 25 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 25 | suppressed |
| Rexulti | Brexpiprazole | 25 | suppressed |
| Risperidone | Risperidone | 25 | suppressed |
| Lorazepam | Lorazepam | 24 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 23 | 12 |
| Allopurinol | Allopurinol | 22 | suppressed |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Loperamide | Loperamide Hcl | 21 | 11 |
| Estradiol (Once Weekly) | Estradiol | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 12 |
| Clobetasol Propionate | Clobetasol Propionate | 18 | suppressed |
| Trulicity | Dulaglutide | 18 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 17 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Creon | Lipase/Protease/Amylase | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 15 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 15 | suppressed |
| Ingrezza | Valbenazine Tosylate | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | 13 |
| Benztropine Mesylate | Benztropine Mesylate | 14 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | suppressed |
| Erythromycin | Erythromycin Base | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Nystatin | Nystatin | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Mirabegron Er | Mirabegron | 13 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Movantik | Naloxegol Oxalate | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Torsemide | Torsemide | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | 11 |
| Colestipol Hcl | Colestipol Hcl | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Ramelteon | Ramelteon | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $25.01 · 1 records | Boston Scientific Corporation | General - Pain Management | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error